Results

Total Results: 1,229 records

Showing results for "adverse event".
Users also searched for: patient safety indicators

61. Cannabis-2023-Surv-Rep-4-Tables-E-1-E-4 (xls file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/cannabis-2023-surv-rep-4-tables-E-1-E-4.xlsx
    January 01, 2023 - Any Adverse Event Intervention B, N of Any Adverse Event (Numerator) Intervention B, N Analyzed for … Any Adverse Event (Denominator) Intervention B, % With Any Adverse Event Intervention C, N of Any Adverse … With Any Adverse Event Intervention D, N of Any Adverse Event (Numberator Intervention D, N Analyzed … A, % With Serious Adverse Event Intervention B, N of Serious Adverse Event (Numerator) Intervention … ) Intervention C, % With Serious Adverse Event Intervention D, N of Serious Adverse Event (Numerator)

62. Cannabis-2023-Surv-Rep-4-Table-E-5 (xls file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/cannabis-2023-surv-rep-4-table-E-5.xlsx
    January 01, 2023 - C % (n/N) Any adverse event 3 months: 35% (19/49) vs. 47% (30/52) vs. NR, RR for A vs. … B 0.72 (95% CI 0.49 to 1.07) Serious adverse events: none in any group Withdrawals due to adverse events … C Any adverse event: 26.1% (91/348) vs. 14.9% (56/377); adjusted OR 1.00 (95% CI 0.64 to 1.58) NR No … B Total patients reporting treatment related adverse event: 21.1% (71/337) vs. 35.0% (118/337), RR 0.60 … B % (n/N) Any adverse event: 88.4% (190/215) vs. 85.2% (184/216), RR 1.02 (95% CI 0.88 to 1.18) Serious

63. Cannabis-2022-Surv-Rep-4-Table-F5 (xls file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/cannabis-2022-surv-rep-4-table-F5.xlsx
    January 01, 2022 - C % (n/N) Any adverse event 3 months: 35% (19/49) vs. 47% (30/52) vs. NR, RR for A vs. … B 0.72 (95% CI 0.49 to 1.07) Serious adverse events: none in any group Withdrawals due to adverse events … C Any adverse event: 26.1% (91/348) vs. 14.9% (56/377); adjusted OR 1.00 (95% CI 0.64 to 1.58) NR No … B Total patients reporting treatment related adverse event: 21.1% (71/337) vs. 35.0% (118/337), RR 0.60 … B % (n/N) Any adverse event: 88.4% (190/215) vs. 85.2% (184/216), RR 1.02 (95% CI 0.88 to 1.18) Serious

64. Evidence-based Practice Center Systematic Review Protocol (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/pdf/gestational-diabetes-screening-diagnosis_research-protocol.pdf
    December 16, 2011 - event; GDM = gestational diabetes mellitus Pregnant women ≥24 weeks’ and <24 weeks’ gestation … For each adverse event, we will record the number of patients in each group and the number of patients … with an adverse event. … We will count each event as if it corresponded to a unique individual. … assumption may overestimate the number of patients that experience an adverse event.

65. Layout 1 (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/cancer-anemia_executive.pdf
    May 01, 2006 - Serious transfusion-related adverse events are uncommon. … Hb Meta-analysis increase >2 mg/dL (95% CI) not done1 3.42 (3.03, 3.86)2 3.36 (2.48, 4.56) Pooled event … 950 Pooled relative risk (95% CI) 1.10 (0.93, 1.29)2 0.63 (0.59, 0.67)2 0.61 (0.52, 0.72) Pooled event … 314 Pooled relative risk (95% CI) 0.86 (0.61, 1.21) 1.69 (1.36, 2.10) 1.44 (0.47, 4.43)3 Pooled event … patients treated with epoetin or darbepoetin experienced a thromboembolic event, compared with 4 percent

66. Executive Summary_Comparative Effectiveness Review No. 263: Management of Postpartum Hypertensive Disorders of Pregnancy (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-263-postpartum-hypertensive-pregnancy-executive-summary.pdf
    May 01, 2023 - Both successful control of hypertension and effect on clinical event outcomes are important outcomes … ) No conclusions (rare event) for patients without prior seizure ✓ No evidence of a difference … with prior eclamptic seizure Seizure (preeclampsia with severe features) No conclusions (rare event … ) No conclusions (rare event) Recurrent seizure (eclampsia) ✓ ✓ Loading dose only MgSO4 regimens … yields shorter time to start breastfeeding No evidence Infant morbidity No conclusions (rare event

67. Layout 1 (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/antipsychotics-children_executive.pdf
    February 01, 2012 - A total of 25 studies compared the adverse event profiles of various SGAs. … event (moderate strength of evidence). … AE = adverse event; CI = confidence interval; EPS = extrapyramidal symptom; FGA = first-generation antipsychotic … Similarly, few conclusions can be drawn regarding the comparison of adverse event profiles across different … Some SGAs are associated with a better adverse-event profile than other SGAs.

68. CER 215 Adverse Effects of Pharmacologic Treatments of Major Depression in Older Adults (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-215-depression-older-adults-comments.pdf
    March 28, 2019 - Severity information, particularly for the outcomes of “any adverse event” and “withdrawal due to … event profiles.” … “The risk of any adverse event…”was not different” instead of “were no different”. … event. … event.

69. Layout 1 (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/atrial-fibrillation-ablation_executive.pdf
    July 01, 2009 - There were 84 studies that reported at least one adverse event associated with RFA. … event. … Atrioesophageal fistula was reported in 26 studies: 5 studies reported 1 case each, with event rates … RFA monitoring and use modalities that are more sensitive to asymptomatic recurrences of AF (e.g., event … All studies should actively collect adverse event data from study participants.

70. Executive Summary_Systematic Review: Psychosocial and Pharmacologic Interventions for Disruptive Behavior in Children and Adolescents (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/disruptive-behavior-disorders-research-executive-summ.pdf
    April 01, 2025 - event, although there were few serious adverse events (SOE: Low) … Adverse effects/harms -- Timing KQs 1-6. Any length of followup -- Setting KQs 1-6. … events compared with placebo and a small increase in the risk of experiencing any adverse event versus … Medication use was associated with an increased risk of experiencing any adverse event, but serious … adverse events were infrequent and not different from placebo.

71. Medical Care Journal Supplement (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/toc.pdf
    January 01, 2007 - Developing Indicators of Inpatient Adverse Drug Events Through Non-Linear Analysis Using Administrative … Real-Time Vaccine Safety Surveillance for the Early Detection of Adverse Events. … Evaluation and Overview of the National Electronic Injury Surveillance System- Cooperative Adverse … Drug Event Surveillance Project (NEISS-CADES). … A Simulation-Based Evaluation of Methods to Estimate the Impact of an Adverse Event on Hospital Length

72. Cer-250-Cannabis-2024-Surv-Rep-Update-Tables-E1-4 (xls file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-250-cannabis-2024-surv-rep-update-tables-e1-4.xlsx
    January 01, 2024 - Any Adverse Event Intervention B, N of Any Adverse Event (Numerator) Intervention B, N Analyzed for … Any Adverse Event (Denominator) Intervention B, % With Any Adverse Event Intervention C, N of Any Adverse … With Any Adverse Event Intervention D, N of Any Adverse Event (Numerator) Intervention D, N Analyzed … A, % With Serious Adverse Event Intervention B, N of Serious Adverse Event (Numerator) Intervention … ) Intervention C, % With Serious Adverse Event Intervention D, N of Serious Adverse Event (Numerator)

73. S81 (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/s81.pdf
    October 01, 2007 - Poisoning and adverse event codes designed for the targeted ADEs had low sensitivities and, when forced … These fields included adverse event codes. … event codes. … drug event surveillance system. … Adverse drug event trigger tool: a practical methodology for measuring medication related harm.

74. Hip-Fracture-Pain Clinician (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/pdf/hip-fracture-pain_clinician.pdf
    May 01, 2011 - and Epidural Anesthesia: The evidence is insufficient to understand the effectiveness, benefits, or adverse … for pain relief, but the data are too limited to draw conclusions about the benefits or harms. ��� Adverse … Events Overall, adverse event rates were similar in both treated and control groups, but studies were … Serious adverse events such as myocardial infarction, stroke, and renal failure were either rarely reported … For all modalities, the evidence is generally inadequate to estimate harms and the incidence of adverse

75. Quantitative Synthesis: Chapter 2. Presenting Different Effects for Different Data Types (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/pdf/ehc-presentation-quantitative-synthesis-chapter-2.pdf
    February 01, 2018 - versus no event … being reciprocal for events and non- events. ► Thus, if switching from event and non-event (e.g., from … Number-Needed-to-Treat-Related Concepts for Assessing Treatment Efficacy in the Presence of Treatment-Induced Adverse … ► Risk difference is not the preferred measure when the event is rare. … Number-Needed-to-Treat-Related Concepts for Assessing Treatment Efficacy in the Presence of Treatment-Induced Adverse

76. Cer-250-Cannabis-2025-Surv-Rep-Update-Tables-E1-4 (xls file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-250-cannabis-2025-surv-rep-update-tables-e1-4.xlsx
    January 01, 2025 - Any Adverse Event Intervention B, N of Any Adverse Event (Numerator) Intervention B, N Analyzed for … Any Adverse Event (Denominator) Intervention B, % With Any Adverse Event Intervention C, N of Any Adverse … With Any Adverse Event Intervention D, N of Any Adverse Event (Numerator) Intervention D, N Analyzed … A, % With Serious Adverse Event Intervention B, N of Serious Adverse Event (Numerator) Intervention … ) Intervention C, % With Serious Adverse Event Intervention D, N of Serious Adverse Event (Numerator)

77. Cer-250-Cannabis-2024-Surv-Rep-Update-Table-E5 (xls file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-250-cannabis-2024-surv-rep-update-table-e5.xlsx
    January 01, 2024 - C % (n/N) Any adverse event 3 months: 35% (19/49) vs. 47% (30/52) vs. NR, RR for A vs. … C Any adverse event: 26.1% (91/348) vs. 14.9% (56/377); adjusted OR 1.00 (95% CI 0.64 to 1.58) NR No … B Total patients reporting treatment related adverse event: 21.1% (71/337) vs. 35.0% (118/337), RR 0.60 … B % (n/N) Any adverse event: 88.4% (190/215) vs. 85.2% (184/216), RR 1.02 (95% CI 0.88 to 1.18) Serious … event U.S.

78. Comparative Effectiveness Review (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/osteoarthritis-pain-2006_appendixes.pdf
    January 01, 2006 - Effects] (374) 6 *DIFLUNISAL/ae [Adverse Effects] (27) 7 *ETODOLAC/ae [Adverse Effects] … (19) 8 *FENOPROFEN/ae [Adverse Effects] (41) 9 *FLURBIPROFEN/ae [Adverse Effects] (41) 10 … /ae [Adverse Effects] (109) 13 *KETOROLAC/ae [Adverse Effects] (16) 14 meclofenamate sodium.mp … /ae [Adverse Effects] (40) 11 *INDOMETHACIN/ae [Adverse Effects] (61) 12 *KETOPROFEN/ae [Adverse … Lumiracoxib compared less favorably with naproxen (0.37% event rate with lumiracoxib v 0.22% event rate

79. Cancer-Anemia-Update Executive (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/cancer-anemia-update_executive.pdf
    April 01, 2013 - Transfusion carries a very low risk of infection and other adverse events, including transfusion reactions … , alloimmunization, overtransfusion, and immune modulation with theoretically possible adverse effects … (For example, adverse events that could be definitively attributed to transfusions were not reported … in any trial included in this review for adverse event outcomes.) … While it is possible that adverse event rates might be somewhat different with lower baseline and target

80. Identification and Treatment of Post-Acute Coronary Syndrome (ACS) Depression: A Systematic Review (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/pdf/acs-depression-research-protocol-amended.pdf
    February 15, 2017 - effects to be considered, such as distinguishing between treatment discontinuation due to adverse effects … effects • Adverse effects of treatment (excluding clinical outcomes listed above) o Weight gain … The safety outcomes will be framed to help identify adverse events, including those from drug therapies … event outcomes. … Definition of Terms ACS Acute Coronary Syndrome ACT Acceptance and commitment therapy AE Adverse